Literature DB >> 22507894

Galangin induces autophagy through upregulation of p53 in HepG2 cells.

Min Wen1, Jun Wu, Hui Luo, Haitao Zhang.   

Abstract

AIM: To investigate the mechanism by which galangin, a polyphenolic compound derived from medicinal herbs,induces autophagy of HepG2 cells.
METHODS: The MTT[3-(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl-tetrazolium bromide]assay was used to measure cell viability. Apoptosis was evaluated by TUNEL assay with flow cytometry, and PARP cleavage was detected by Western blotting. Autophagy was measured by fluorescence microscopy and transmission electron microscopy. Protein expressions were detected by Western blotting. Pifithrin- was used for pretreatment and siRNA was used to knock down p53 expression to explore the pathway mediated by galangin in HepG2 cells. Furthermore, Hep3B cells were used to express the exogenous wild-type p53.
RESULTS: Galangin treatment inhibited cell proliferation and induced autophagy (130 μ mol/l) and apoptosis (370 μ mol/l). In particular, galangin treatment in HepG2 cells caused (1) an accumulation of autophagosomes, (2) elevated levels of microtubule-associated protein light chain 3, and (3) an increased percentage of cells with vacuoles. p53 expression was also increased. The galangin-induced autophagy was attenuated by the inhibition of p53 in HepG2 cells, and overexpression of p53 in Hep3B cells restored the galangin-induced higher percentage of cells with vacuoles to normal level.
CONCLUSION: Our results indicate that galangin not only induced apoptosis but also prompted cell autophagy indifferent concentrations. Galangin mediates autophagy through a p53-dependent pathway in HepG2 cells. Our findings may help in the discovery of a chemotherapeutic drug with the novel pattern of inhibiting cell proliferation for the treatment of hepatocellular carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507894     DOI: 10.1159/000337041

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  12 in total

Review 1.  Key autophagic targets and relevant small-molecule compounds in cancer therapy.

Authors:  X-P Tong; Y Chen; S-Y Zhang; T Xie; M Tian; M-R Guo; R Kasimu; L Ouyang; J-H Wang
Journal:  Cell Prolif       Date:  2014-12-04       Impact factor: 6.831

Review 2.  Untangling knots between autophagic targets and candidate drugs, in cancer therapy.

Authors:  Tao Xie; Si-Jia Li; Ming-Rui Guo; Yue Wu; Hang-Yu Wang; Ke Zhang; Xue Zhang; Liang Ouyang; Jie Liu
Journal:  Cell Prolif       Date:  2015-02-04       Impact factor: 6.831

3.  Attenuation of airway smooth muscle contractility via flavonol-mediated inhibition of phospholipase-Cβ.

Authors:  Amy Brown; Jennifer Danielsson; Elizabeth A Townsend; Yi Zhang; Jose F Perez-Zoghbi; Charles W Emala; George Gallos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-15       Impact factor: 5.464

4.  AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for alzheimer's disease.

Authors:  Olivier Descamps; Patricia Spilman; Qiang Zhang; Clare P Libeu; Karen Poksay; Olivia Gorostiza; Jesus Campagna; Barbara Jagodzinska; Dale E Bredesen; Varghese John
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.

Authors:  Min Ae Han; Dong Hee Lee; Seon Min Woo; Bo Ram Seo; Kyoung-Jin Min; Shin Kim; Jong-Wook Park; Sang Hyun Kim; Yung Hyun Choi; Taeg Kyu Kwon
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

Review 6.  Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.

Authors:  Chen-Yi Liao; Ching-Chang Lee; Chi-chang Tsai; Chao-Wen Hsueh; Chih-Chiang Wang; I-Hung Chen; Ming-Kai Tsai; Mei-Yu Liu; An-Tie Hsieh; Kuan-Jen Su; Hau-Ming Wu; Shih-Chung Huang; Yi-Chen Wang; Chien-Yao Wang; Shu-Fang Huang; Yen-Cheng Yeh; Ren-Jy Ben; Shang-Tao Chien; Chin-Wen Hsu; Wu-Hsien Kuo
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

7.  Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy.

Authors:  Xinxu Zhang; Yuanyuan Deng; Juan Xiang; Huixia Liu; Jiani Zhang; Jie Liao; Ke Chen; Bo Liu; Jun Liu; Ying Pu
Journal:  Drug Des Devel Ther       Date:  2020-08-19       Impact factor: 4.162

Review 8.  Autophagy: Mechanisms and Therapeutic Potential of Flavonoids in Cancer.

Authors:  Xuening Pang; Xiaoyi Zhang; Yuhuan Jiang; Quanzhong Su; Qun Li; Zichao Li
Journal:  Biomolecules       Date:  2021-01-21

9.  Galangin Reverses H2O2-Induced Dermal Fibroblast Senescence via SIRT1-PGC-1α/Nrf2 Signaling.

Authors:  Jian-Jr Lee; Shang-Chuan Ng; Jia-Yun Hsu; Hsun Liu; Chih-Jung Chen; Chih-Yang Huang; Wei-Wen Kuo
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

10.  Galangin Induces Autophagy via Deacetylation of LC3 by SIRT1 in HepG2 Cells.

Authors:  Xv Li; Yajun Wang; Yuzhen Xiong; Jun Wu; Hang Ding; Xiaoyi Chen; Liubo Lan; Haitao Zhang
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.